Evidence map›Paper›PMID 10540187›Full record

ArticleClinical and experimental immunology1999

Activation of human neutrophils by mycobacterial phenolic glycolipids.

J Fäldt, C Dahlgren, A Karlsson, A M Ahmed, D E Minnikin, M Ridell

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental immunology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.American journal of respiratory and critical care medicine · 2011
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

J FäldtDepartment of Medical Microbiology and Immunology, Göteborg University, Göteborg, Sweden. jenny.faldt@microbio.gu.se
C Dahlgren
A Karlsson
A M Ahmed
D E Minnikin
M Ridell
University of Gothenburg · SENewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between mycobacterial phenolic glycolipids (PGLs) and phagocytes was studied. Human neutrophils were allowed to interact with each of four purified mycobacterial PGLs and the neutrophil production of reactive oxygen metabolites was followed kinetically by luminol-/isoluminol-amplified chemiluminescence. The PGLs from Mycobacterium tuberculosis and Mycobacterium kansasii, respectively, were shown to stimulate the production of oxygen metabolites, while PGLs from Mycobacterium marinum and Mycobacterium bovis BCG, respectively, were unable to induce an oxidative response. Periodate treatment of the M. tuberculosis PGL decreased the production of oxygen radicals, showing the importance of the PGL carbohydrate moiety for the interaction. The activation, however, could not be inhibited by rhamnose or fucose, indicating a complex interaction which probably involves more than one saccharide unit. This is in line with the fact that the activating PGLs from M. tuberculosis and M. kansasii contain tri- and tetrasaccharides, respectively, while the nonactivating PGLs from M. marinum and M. bovis BCG each contain a monosaccharide. The complement receptor 3 (CR3) has earlier been shown to be of importance for the phagocyte binding of mycobacteria, but did not appear to be involved in the activation of neutrophils by PGLs. The subcellular localization of the reactive oxygen metabolites formed was related to the way in which the glycolipids were presented to the cells.

Indexed as

Neutrophil ActivationAntigens, BacterialCarbohydrate MetabolismCarbohydratesComplement Inactivator ProteinsCytoplasmic GranulesCytoskeletonEnzyme InductionGlycolipidsHumansMacrophage-1 AntigenMonosaccharidesMycobacterium bovisMycobacterium kansasiiMycobacterium marinumMycobacterium tuberculosisAntigens, BacterialCarbohydratesComplement Inactivator ProteinsGlycolipidsMacrophage-1 AntigenMonosaccharidesNADPH Oxidasesphenolic glycolipid I, Mycobacterium leprae

Identifiers

PMID10540187
PMCPMC1905428
OpenAlexW1992058441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.